APA (7th ed.) Citation

Zhou, X., Zhang, L., Lin, X., Chen, X., Liu, H., Yuan, X., . . . Yang, J. (2023). Thrombospondin 2 is a novel biomarker of essential hypertension and associated with nocturnal Na + excretion and insulin resistance. Clinical and experimental hypertension (1993), 45(1), 2276029. https://doi.org/10.1080/10641963.2023.2276029

Chicago Style (17th ed.) Citation

Zhou, Xiaoxin, et al. "Thrombospondin 2 Is a Novel Biomarker of Essential Hypertension and Associated with Nocturnal Na + Excretion and Insulin Resistance." Clinical and Experimental Hypertension (1993) 45, no. 1 (2023): 2276029. https://doi.org/10.1080/10641963.2023.2276029.

MLA (9th ed.) Citation

Zhou, Xiaoxin, et al. "Thrombospondin 2 Is a Novel Biomarker of Essential Hypertension and Associated with Nocturnal Na + Excretion and Insulin Resistance." Clinical and Experimental Hypertension (1993), vol. 45, no. 1, 2023, p. 2276029, https://doi.org/10.1080/10641963.2023.2276029.